Bupivacaine HCL Sterile Injection Recalled for Sterility Assurance Concerns
Tailstorm Health Inc. is recalling bupivacaine HCL sterile injection vials nationwide due to FDA inspection findings regarding concerns with the sterile manufacturing process.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable drug with identified manufacturing process defects affecting sterility assurance. Per the rubric, FDA Class II recalls are scored at 4 (Severe) when there are manufacturing or process integrity concerns with injectable products that could lead to serious adverse health consequences, even without reported illnesses.
Plain-English summary
Tailstorm Health Inc. is recalling bupivacaine HCL sterile injection, USP with epinephrine 1:200,000, 50 mg/10mL, 0.5% (5mg/mL) in 10 mL sterile single-dose vials. The recall affects 975 vials distributed nationwide in the United States.
An FDA inspection identified concerns with the sterile manufacturing process, creating a lack of assurance of sterility for the affected vials. The recalled lot numbers are 2502005 (expiration 2/20/26) and 2502006 (expiration 2/23/2026).
Healthcare providers who have received these vials should stop using them immediately and contact Tailstorm Health Inc. for instructions on return or destruction. Patients who may have received this product should consult with their healthcare provider about the recall.
The recalled product
- Product
- BUPIVAcaine HCL Sterile injection, USP w/EPINEPHRINE 1:200,000, 50 mg/10mL, 0.5%, (5mg/mL), 10 mL Sterile Single-Dose Vial, Rx Only, For Nerve Block, Caudal & Epidural Anesthesia Only, Warning: Contains Sulfites, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S
- Manufacturer
- Tailstorm Health INC
- Category
- Drug — Sterile Injectable
- Hazard
- lack-of-sterility
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #s: 2502005
- Exp. 2/20/26
- 2502006
- Exp 2/23/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22